Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma
1 clinical trials · Condition
◉ Watch Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma (NCT02211131) | Amgen | 2015-02-03 |
Track Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.